Details for New Drug Application (NDA): 211448
✉ Email this page to a colleague
NDA 211448 describes MEZOFY, which is a drug marketed by Cmg Pharm Co Ltd and is included in one NDA. There is one patent protecting this drug. Additional details are available on the MEZOFY profile page.
The generic ingredient in MEZOFY is aripiprazole. There is one drug master file entry for this compound. Fifty suppliers are listed for this compound. Additional details are available on the aripiprazole profile page.
The generic ingredient in MEZOFY is aripiprazole. There is one drug master file entry for this compound. Fifty suppliers are listed for this compound. Additional details are available on the aripiprazole profile page.
Summary for 211448
| Tradename: | MEZOFY |
| Applicant: | Cmg Pharm Co Ltd |
| Ingredient: | aripiprazole |
| Patents: | 1 |
Medical Subject Heading (MeSH) Categories for 211448
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | FILM;ORAL | Strength | 5MG | ||||
| Approval Date: | Apr 15, 2025 | TE: | RLD: | Yes | |||||
| Patent: | 9,694,008 | Patent Expiration: | Aug 7, 2033 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | FILM;ORAL | Strength | 10MG | ||||
| Approval Date: | Apr 15, 2025 | TE: | RLD: | Yes | |||||
| Patent: | 9,694,008 | Patent Expiration: | Aug 7, 2033 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | FILM;ORAL | Strength | 15MG | ||||
| Approval Date: | Apr 15, 2025 | TE: | RLD: | Yes | |||||
| Patent: | 9,694,008 | Patent Expiration: | Aug 7, 2033 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Complete Access Available with Subscription
